Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948311 · ClinicalTrials.gov registry record
Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 279
- Enrollment target
NCT00948311: Completed study, sponsored by HealthPartners Institute.
NCT00948311 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 279 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948311 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 279 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and validate a survey instrument to be used by persons with type 1 diabetes aged 12 and older to screen for an eating disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2008-12 |
| Est. Completion | 2015-12 |
What the finished NCT00948311 record still lists
NCT00948311 is an observational study that tracks outcomes without assigning an intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00948311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00948311 about?
NCT00948311 is a clinical study titled "Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.". The purpose of this study is to develop and validate a survey instrument to be used by persons with type 1 diabetes aged 12 and older to screen for an eating disorder.
What is the current status of trial NCT00948311?
This trial is currently completed. The enrollment target is 279 participants. The study started on 2008-12. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00948311?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04783857 · 279 participants · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
- NCT05407324 · 279 participants · Phase 2
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- NCT06299748 · 279 participants
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- NCT06582784 · 279 participants · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia